Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Healthy Returns LILLY DRN Health care industry
From CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
Tags Mad Money S&P 500 Coinbase Global Inc
From CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
Tags Investment Strategy Business Stock markets
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Pharmaceuticals Business LILLY DRN
From CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
Tags Retail industry Personal investing LILLY DRN
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags AstraZeneca PLC Social issues Health & Science
From CNBC.com News
Jim Cramer says CEOs must properly explain the bad news in every quarter
Tags Stock Picks Investment strategy Markets
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
Tags LILLY DRN Health care industry Pharmaceuticals
From CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
Tags Danaher Corp CNBC Investing Club Chipotle Mexican Grill Inc
From CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
Tags Earnings Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags KB Home Microsoft Corp Trump Media & Technology Group Corp
From CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
Tags stocks Stock markets Business
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Biotechnology Companies US: News
From CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
Tags stocks Stock markets LILLY DRN
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags LILLY DRN Healthy Returns Microsoft Corp
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Biotechnology US: News Companies
From CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
Tags Investing Investment strategy Amazon/com Inc
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Health care industry Healthy Returns LILLY DRN
From CNBC.com News
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Tags Social issues Business News Health & Science
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Biotechnology Europe: Top News And Analysis Novo Nordisk A/S
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Valero Energy Corp Tencent Holdings Ltd Diamondback Energy Inc
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Technology Investment strategy Stellantis NV
From CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
Tags LILLY DRN Health care industry Science
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.